Patents by Inventor Yu-ichiro Satoh

Yu-ichiro Satoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the dry powder formulation of interferon
    Publication number: 20030035778
    Abstract: According to the present invention, methods and compositions are provided for spray-dried, interferon-based dry powder compositions, particularly interferon-beta. The compositions are useful for treating conditions in humans that are responsive to treatment with interferons. In particular, the methods of the present invention rely on spray drying to produce stable, high-potency dry powder formulations of interferons, including but not limited to IFN-beta. Surprisingly, it has been found that IFN can be prepared in high potency, dry powder formulations by spray drying. Such dry powder formulations find particular utility in the pulmonary delivery of IFN.
    Type: Application
    Filed: September 17, 2002
    Publication date: February 20, 2003
    Inventors: Robert Platz, Shigenobu Kimura, Yu-Ichiro Satoh, Linda C. Foster
  • Methods and compositions for the dry powder formulation of interferons
    Patent number: 6479049
    Abstract: According to the present invention, methods and compositions are provided for spray-dried, interferon-based dry powder compositions, particularly interferon-beta. The compositions are useful for treating conditions in humans that are responsive to treatment with interferons. In particular, the methods of the present invention rely on spray drying to produce stable, high-potency dry powder formulations of interferons, including but not limited to IFN-beta. Surprisingly, it has been found that IFN can be prepared in high potency, dry powder formulations by spray drying. Such dry powder formulations find particular utility in the pulmonary delivery of IFN.
    Type: Grant
    Filed: February 17, 2000
    Date of Patent: November 12, 2002
    Assignee: Inhale Therapeutic Systems, Inc.
    Inventors: Robert M. Platz, Shigenobu Kimura, Yu-ichiro Satoh, Linda C. Foster
  • Methods and compositions for the dry powder formulation of interferons
    Patent number: 6231851
    Abstract: According to the present invention, methods and compositions are provided for spray-dried, interferon-based dry powder compositions, particularly interferon-beta. The compositions are useful for treating conditions in humans that are responsive to treatment with interferons. In particular, the methods of the present invention rely on spray drying to produce stable, high-potency dry powder formulations of interferons, including but not limited to IFN-beta. Surprisingly, it has been found that IFN can be prepared in high potency, dry powder formulations by spray drying. Such dry powder formulations find particular utility in the pulmonary delivery of IFN.
    Type: Grant
    Filed: July 14, 1997
    Date of Patent: May 15, 2001
    Assignee: Inhale Therapeutic Systems
    Inventors: Robert M. Platz, Shigenobu Kimura, Yu-ichiro Satoh, Linda C. Foster
  • Methods and compositions for the dry powder formulation of interferons
    Patent number: 6123936
    Abstract: According to the present invention, methods and compositions are provided for spray-dried, interferon-based dry powder compositions, particularly interferon-beta. The compositions are useful for treating conditions in humans that are responsive to treatment with interferons. In particular, the methods of the present invention rely on spray drying to produce stable, high-potency dry powder formulations of interferons, including but not limited to IFN-beta. Surprisingly, it has been found that IFN can be prepared in high potency, dry powder formulations by spray drying. Such dry powder formulations find particular utility in the pulmonary delivery of IFN.
    Type: Grant
    Filed: November 22, 1999
    Date of Patent: September 26, 2000
    Assignee: Inhale Therapeutics Systems, Inc.
    Inventors: Robert M. Platz, Shigenobu Kimura, Yu-ichiro Satoh, Linda C. Foster
  • Corneal angiogenesis inhibitor
    Patent number: 5948403
    Abstract: The present invention relates to a corneal angiogenesis inhibitor which has interferon .beta. as an active ingredient and which is used for preventing and treating neovascularization or invasion of vessels in the cornea.
    Type: Grant
    Filed: January 7, 1997
    Date of Patent: September 7, 1999
    Assignee: Toray Industries, Inc.
    Inventors: Saburo Sone, Akemi Kajita, Yu-ichiro Satoh